Effectiveness and safety of bromocriptine when it is combined with metformin in Indian patients with type II diabetes mellitus
Phase 4
Completed
- Conditions
- Health Condition 1: null- Moderate cases of type II diabetes mellitusHealth Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2012/05/002659
- Lead Sponsor
- Dr Nilanjan Sengupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Age > 18 yrs
2. Diagnosed cases with type 2 diabetes mellitus
3. HbA1C >= 6.5 & <= 10
Exclusion Criteria
1. Female patients who are pregnant or lactatin
2. FPG 250mg/dl, PPPG 350mg/dl
3. Co-morbid cardiovascular, renal and psychatric complications
4. Co-administration of drugs that are likely to interact with bromocriptine or metformin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1CTimepoint: 12 week visit
- Secondary Outcome Measures
Name Time Method Fasting and post prandial plasma glucoseTimepoint: 4, 8 and 12 week visit